Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: A multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte

Journal of Clinical Oncology

Volumn 14, Issue 2, 1996, Pages 514-519

  Solal Celigny P ^a   Brice, P ^a   Brousse, N ^a   Caspard, H ^a   Bastion, Y ^a   Haioun C ^a   Bosly, A ^a   Tilly, H ^a   Bordessoule, D ^a   Sebban, C ^a   Harousseau, J L ^a   Morel, P ^a   Dupas, B ^a   Plassart, F ^a   Vasile, N ^a   Fort, N ^a   Leporrier, M ^a  

^a Groupe d'Etude des Lymphomes de l'Adulte (GELA)   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDARABINE PHOSPHATE;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FOLLICULAR LYMPHOMA; GRANULOCYTOPENIA; HEPATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 9044252315     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.2.514     Document Type: Article

References (21)

1. Horning SJ: Natural history of and therapy for the indolent non-Hodgkin's lymphomas. Semin Oncol 20:75-88, 1993
2. Ross SR, McTavish D, Faulds D: Fludarabine. A review of its pharmacological properties and therapeutic potential in malignancy. Drugs 45:737-759, 1993
3. Plunkett W, Gandhi V, Huang Pm et al: Fludarabine: Pharmacokinetics, mechanisms of action, and rationales for combination therapies. Semin Oncol 20:2-12, 1993 (suppl 7)
4. Keating MJ, Estey E, O'Brien S, et al: Clinical experience with fludarabine in leukaemia. Drugs 47:39-49, 1994 (suppl 6)
5. Leiby JM, Snider KM, Kraut EH, et al: Phase II trial of 9-β-D-Arabinofuranosyl-2-fluoroadenine 5′-monophosphate in non-Hodgkin's lymphoma: Prospective comparison of response with deoxycytidine kinase activity. Cancer Res 47:2719-2722, 1987
6. Redman JR, Cabanillas F, Velasquez WS, et al: Phase II trial of fludarabine phosphate in lymphoma: An effective new agent in low-grade lymphoma. J Clin Oncol 10:790-794, 1992
7. Hochster HS, Kim K, Green MD, et al: Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: Results of an Eastern Cooperative Oncology Group study. J Clin Oncol 10:28-32, 1992
8. Hiddeman W, Unterhalt M, Pott C, et al: Fludarabine single-agent therapy for relapsed low-grade non-Hodgkin's lymphomas: A phase II study of the German Low-Grade Non-Hodgkin's Lymphoma Study Group. Semin Oncol 20:28-31, 1993 (suppl 7)
9. Pigaditou A, Rohatiner AZS, Whelan JS, et al: Fludarabine in low-grade lymphoma. Semin Oncol 20:24-27, 1993 (suppl 7)
10. Zinzani PL, Lauria F, Rondelly D, et al: Fludarabine: An active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma. Ann Oncol 4:575-578, 1993
11. Dumontet C, Bastion Y, Bazin M, et al: Fludarabine treatment in low-grade non-Hodgkin's lymphoma: results of the Lyon-Sud experience. Fifth International Conference on Malignant Lymphoma, Lugano, Switzerland, 1993 (abstr 108)
12. Solal-Céligny P, Lepage E, Brousse N, et al: Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. N Engl J Med 329:1608-1614, 1993
13. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981
14. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
15. Cox DR: The Analysis of Binary Data. New York, NY, Chapman & Hall, 1970
16. Hryniuk W, Goodyear M: The calculation of received dose intensity. J Clin Oncol 8:1935-1937, 1990
17. Gisselbrecht C, Cosset JM: Treatment of low-grade non-Hodgkin's lymphomas, in Solal-Céligny P, Brousse N, Reyes F, et al (eds): Non-Hodgkin's Lymphomas, London, United Kingdom, Manson, 1993, pp 317-336
18. Turner JWA, Parsonage MJ: Neuralgic amyotrophy (paralytic brachial neuritis). Lancet 2:209-212, 1957
19. Kane GC, Mc Michael AJ, Patrick H, et al: Pulmonary toxicity and acute respiratory failure associated with fludarabine monophosphate. Respir Med 86:261-263, 1992
20. McLaughlin P, Hagemeister FB, Swan F, et al: Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma. J Clin Oncol 12:575-579, 1994
21. Hochster H, Oken M, Bennett J, et al: Efficacy of cyclophosphamide and fludarabine as first line therapy of low-grade non-Hodgkin's lymphoma. Blood 84:10, 1994 (suppl, abstr 1517)